Loading viewer...
investor_presentation
Format: PDF investor_presentation
SCOR records a net income of EUR 339 million, demonstrating its shock -absorbing capacity, and launches a EUR 200 million share buy -back programSCOR First nine months 2021 results October 27, 2021
presentation
Pfizer